179 related articles for article (PubMed ID: 12481816)
1. Surfactant supplementation in the lung.
Anzueto A
Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
[TBL] [Abstract][Full Text] [Related]
2. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
3. The role of exogenous surfactant in the treatment of acute lung injury.
Lewis JF; Veldhuizen R
Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
[TBL] [Abstract][Full Text] [Related]
4. The future of surfactant therapy during ALI/ARDS.
Lewis JF; Veldhuizen RA
Semin Respir Crit Care Med; 2006 Aug; 27(4):377-88. PubMed ID: 16909371
[TBL] [Abstract][Full Text] [Related]
5. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy.
Taeusch HW
Biol Neonate; 2000 May; 77 Suppl 1():2-8. PubMed ID: 10828579
[TBL] [Abstract][Full Text] [Related]
7. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
Robertson B
Monaldi Arch Chest Dis; 1998 Feb; 53(1):64-9. PubMed ID: 9632910
[TBL] [Abstract][Full Text] [Related]
8. Surfactant and the adult respiratory distress syndrome.
Lewis JF; Jobe AH
Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
[TBL] [Abstract][Full Text] [Related]
9. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
[TBL] [Abstract][Full Text] [Related]
10. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF.
Häfner D; Germann PG; Hauschke D
Pulm Pharmacol; 1994 Oct; 7(5):319-32. PubMed ID: 7626919
[TBL] [Abstract][Full Text] [Related]
11. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
[TBL] [Abstract][Full Text] [Related]
12. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
[TBL] [Abstract][Full Text] [Related]
13. Advances with surfactant.
Turell DC
Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
[TBL] [Abstract][Full Text] [Related]
14. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
Meng SS; Chang W; Lu ZH; Xie JF; Qiu HB; Yang Y; Guo FM
BMC Pulm Med; 2019 Jan; 19(1):9. PubMed ID: 30626363
[TBL] [Abstract][Full Text] [Related]
15. Surfactant treatment for congenital heart disease patients with acute respiratory distress syndrome.
Alten JA; Borasino S; Pearce FB; Dabal RJ; Kirklin JK
Congenit Heart Dis; 2010; 5(6):624-8. PubMed ID: 21106025
[TBL] [Abstract][Full Text] [Related]
16. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
[TBL] [Abstract][Full Text] [Related]
17. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome.
Holm BA; Matalon S
Anesth Analg; 1989 Dec; 69(6):805-18. PubMed ID: 2686493
[TBL] [Abstract][Full Text] [Related]
18. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
[TBL] [Abstract][Full Text] [Related]
19. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
Kozlov IA; Poptsov VN
Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
[TBL] [Abstract][Full Text] [Related]
20. Surfactant therapy for acute lung injury/acute respiratory distress syndrome.
Haitsma JJ; Papadakos PJ; Lachmann B
Curr Opin Crit Care; 2004 Feb; 10(1):18-22. PubMed ID: 15166845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
